These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
228 related articles for article (PubMed ID: 8229967)
1. Hormonal background of canine and feline mammary tumours. Rutteman GR; Misdorp W J Reprod Fertil Suppl; 1993; 47():483-7. PubMed ID: 8229967 [TBL] [Abstract][Full Text] [Related]
2. Comparison of steroid receptor expression in normal, dysplastic, and neoplastic canine and feline mammary tissues. Millanta F; Calandrella M; Bari G; Niccolini M; Vannozzi I; Poli A Res Vet Sci; 2005 Dec; 79(3):225-32. PubMed ID: 16054892 [TBL] [Abstract][Full Text] [Related]
3. Receptors for oestrogen, progesterone and epidermal growth factor in normal and tumorous canine mammary tissues. Donnay I; Rauïs J; Wouters-Ballman P; Devleeschouwer N; Leclercq G; Verstegen JP J Reprod Fertil Suppl; 1993; 47():501-12. PubMed ID: 8229969 [TBL] [Abstract][Full Text] [Related]
4. Metallothionein expression in canine and feline mammary and melanotic tumours. Dincer Z; Jasani B; Haywood S; Mullins JE; Fuentealba IC J Comp Pathol; 2001; 125(2-3):130-6. PubMed ID: 11578128 [TBL] [Abstract][Full Text] [Related]
5. Role of steroid hormones and prolactin in canine mammary cancer. Queiroga FL; Pérez-Alenza MD; Silvan G; Peña L; Lopes C; Illera JC J Steroid Biochem Mol Biol; 2005 Feb; 94(1-3):181-7. PubMed ID: 15862964 [TBL] [Abstract][Full Text] [Related]
6. Hormones and mammary tumour disease in the female dog: an update. Rutteman GR In Vivo; 1990; 4(1):33-40. PubMed ID: 2103839 [TBL] [Abstract][Full Text] [Related]
7. Prolactin binding in benign and malignant mammary tissue of female dogs. Rutteman GR; Willekes-Koolschijn N; Bevers MM; Van der Gugten AA; Misdorp W Anticancer Res; 1986; 6(4):829-35. PubMed ID: 3019223 [TBL] [Abstract][Full Text] [Related]
8. Steroid receptors in mammary tumours of the cat. Rutteman GR; Blankenstein MA; Minke J; Misdorp W Acta Endocrinol (Copenh); 1991; 125 Suppl 1():32-7. PubMed ID: 1801501 [TBL] [Abstract][Full Text] [Related]
9. [Hormones and mammary tumors in the bitch: a review]. Rutteman GR Tijdschr Diergeneeskd; 1992 Feb; 117(3):71-7, 81. PubMed ID: 1736405 [TBL] [Abstract][Full Text] [Related]
10. The role of vascular endothelial growth factor and its receptor Flk-1/KDR in promoting tumour angiogenesis in feline and canine mammary carcinomas: a preliminary study of autocrine and paracrine loops. Millanta F; Silvestri G; Vaselli C; Citi S; Pisani G; Lorenzi D; Poli A Res Vet Sci; 2006 Dec; 81(3):350-7. PubMed ID: 16556453 [TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical expression of Epidermal Growth Factor Receptor (EGFR) in canine mammary tissues. Gama A; Gärtner F; Alves A; Schmitt F Res Vet Sci; 2009 Dec; 87(3):432-7. PubMed ID: 19464036 [TBL] [Abstract][Full Text] [Related]
12. Progestagens and mammary tumours in dogs and cats. Misdorp W Acta Endocrinol (Copenh); 1991; 125 Suppl 1():27-31. PubMed ID: 1839343 [TBL] [Abstract][Full Text] [Related]
13. Expression of TopBP1 in canine mammary neoplasia in relation to histological type, Ki67, ERalpha and p53. Morris JS; Nixon C; King OJ; Morgan IM; Philbey AW Vet J; 2009 Mar; 179(3):422-9. PubMed ID: 18314357 [TBL] [Abstract][Full Text] [Related]
14. Molecular phenotype of primary mammary tumours and distant metastases in female dogs and cats. Beha G; Muscatello LV; Brunetti B; Asproni P; Millanta F; Poli A; Benazzi C; Sarli G J Comp Pathol; 2014; 150(2-3):194-7. PubMed ID: 24060151 [TBL] [Abstract][Full Text] [Related]
15. Expression and significance of PTEN in canine mammary gland tumours. Qiu C; Lin D; Wang J; Wang L Res Vet Sci; 2008 Oct; 85(2):383-8. PubMed ID: 18082231 [TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical detection of progesterone and cellular proliferation in canine mammary tumours. Thuróczy J; Reisvaag GJ; Perge E; Tibold A; Szilágyi J; Balogh L J Comp Pathol; 2007; 137(2-3):122-9. PubMed ID: 17645888 [TBL] [Abstract][Full Text] [Related]
17. Quantification of VEGF-C expression in canine mammary tumours. Qiu C; Lin DD; Wang HH; Qiao CH; Wang J; Zhang T Aust Vet J; 2008 Jul; 86(7):279-82. PubMed ID: 18616481 [TBL] [Abstract][Full Text] [Related]
18. Reduced PTEN protein expression and its prognostic implications in canine and feline mammary tumors. Ressel L; Millanta F; Caleri E; Innocenti VM; Poli A Vet Pathol; 2009 Sep; 46(5):860-8. PubMed ID: 19429983 [TBL] [Abstract][Full Text] [Related]
19. Endocrine control of canine mammary neoplasms: serum reproductive hormone levels and tissue expression of steroid hormone, prolactin and growth hormone receptors. Spoerri M; Guscetti F; Hartnack S; Boos A; Oei C; Balogh O; Nowaczyk RM; Michel E; Reichler IM; Kowalewski MP BMC Vet Res; 2015 Sep; 11():235. PubMed ID: 26370564 [TBL] [Abstract][Full Text] [Related]
20. Expression levels of the focal adhesion-associated proteins paxillin and p130CAS in canine and feline mammary tumors. Scibelli A; d'Angelo D; Pelagalli A; Tafuri S; Avallone L; Della Morte R; Staiano N Vet Res; 2003; 34(2):193-202. PubMed ID: 12657211 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]